Fluacrypyrim Protects Hematopoietic Stem and Progenitor Cells against Irradiation via Apoptosis Prevention
Molecules · 09.02.2024 · 29 (4) · 816
DOI: 10.3390/molecules29040816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 09.02.2024. Verfasst von Xuewen Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Radiobiology, Department of Experimental Hematology and Biochemistry, Beijing Institute of Radiation Medicine, Beijing 100…. Hauptthemen laut MEDLINE: Apoptosis Regulatory Proteins, Hematopoietic Stem Cells, Pyrimidines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ionizing radiation (IR)-induced hematopoietic injury has become a global concern in the past decade. The underlying cause of this condition is a compromised hematopoietic reserve, and this kind of hematopoietic injury could result in infection or bleeding, in addition to lethal mishaps. Therefore, developing an effective treatment for this condition is imperative. Fluacrypyrim (FAPM) is a recognized effective inhibitor of STAT3, which exhibits anti-inflammation and anti-tumor effects in hematopoietic disorders. In this context, the present study aimed to determine whether FAPM could serve as a curative agent in hematopoietic-acute radiation syndrome (H-ARS) after total body irradiation (TBI). The results revealed that the peritoneally injection of FAPM could effectively promote mice survival after lethal dose irradiation. In addition, promising recovery of peripheral blood, bone marrow (BM) cell counts, hematopoietic stem cell (HSC) cellularity, BM colony-forming ability, and HSC reconstituting ability upon FAPM treatment after sublethal dose irradiation was noted. Furthermore, FAPM could reduce IR-induced apoptosis in hematopoietic stem and progenitor cells (HSPCs) both in vitro and in vivo. Specifically, FAPM could downregulate the expressions of p53-PUMA pathway target genes, such as Puma, Bax, and Noxa. These results suggested that FAPM played a protective role in IR-induced hematopoietic damage and that the possible underlying mechanism was the modulation of apoptotic activities in HSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory for Radiobiology, Department of Experimental Hematology and Biochemistry, Beijing Institute of Radiation Medicine, Beijing 100850, China.
- The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215000, China.
- School of Life Science, Anhui Medical University, Hefei 230032, China.
ORCID-Profile: Xuewen Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Qiao, Z., Guan, B., Wang, F., Shen, X., Shu, H., Shan, Y., Cong, Y., Xing, S., & Yu, Z. (2024). Fluacrypyrim Protects Hematopoietic Stem and Progenitor Cells against Irradiation via Apoptosis Prevention. Molecules, 29(4), 816. https://doi.org/10.3390/molecules29040816
Vancouver
Zhang X, Qiao Z, Guan B, Wang F, Shen X, Shu H, et al. Fluacrypyrim Protects Hematopoietic Stem and Progenitor Cells against Irradiation via Apoptosis Prevention. Molecules. 2024;29(4):816. doi:10.3390/molecules29040816
BibTeX
@article{Zhang2024,
author = {Zhang, Xuewen and Qiao, Zizhi and Guan, Bo and Wang, Fangming and Shen, Xing and Shu, Hui and Shan, Yajun and Cong, Yuwen and Xing, Shuang and Yu, Zuyin},
title = {Fluacrypyrim Protects Hematopoietic Stem and Progenitor Cells against Irradiation via Apoptosis Prevention},
journal = {Molecules},
year = {2024},
volume = {29},
number = {4},
pages = {816},
doi = {10.3390/molecules29040816}
}
EUVIMED